1932
0
  1. Home
  2. A-Z Publications
  3. Annual Review of Medicine
  4. Volume 49, 1998
  5. Article

Annual Review of Medicine

Volume 49, 1998

Hereditary Breast Cancer

Abstract

Genetic predisposition is responsible for 5–10% of all breast cancer, and a much larger percent of early-onset disease. Within the past few years, a number of genes associated with a high risk of breast cancer have been identified, including , , p53, and the Cowden disease gene /. These genes appear to function as tumor suppressors, and although their mutation frequency in the general population is low, certain populations have a carrier frequency of up to 1% for particular and mutations. The isolation of these genes is likely to provide important insight into the pathogenesis of human cancer. The clinical application of these molecular discoveries raises controversial issues regarding presymptomatic testing for patients suspected of harboring cancer predisposing mutations.

Keyword(s): BRCA1, BRCA2, breast cancer, genetic predisposition
Loading

Article metrics loading...

/content/journals/10.1146/annurev.med.49.1.425
1998-02-01
2024-04-18
Loading full text...

Full text loading...

/deliver/fulltext/med/49/1/annurev.med.49.1.425.html?itemId=/content/journals/10.1146/annurev.med.49.1.425&mimeType=html&fmt=ahah

Literature Cited

  1. Brocca P. 1866. Traites des tumeurs.. 180
  2. Claus E, Risch N, Thompson W. 1991. Genetic analysis of breast cancer in the cancer and steroid hormone study.. Am. J. Hum. Genet. 48:232–42 [Google Scholar]
  3. Hall JM, Lee MK, Newman B. et al. 1990. Linkage of early-onset breast cancer to chromosome 17q21.. Science 250:1684–89 [Google Scholar]
  4. Miki Y, Swensen J, Shattuck-Eidens D. et al. 1994. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.. Science 266:66–71 [Google Scholar]
  5. Knudson A. 1971. Mutation and cancer: a statistical study of retinoblastoma.. Proc. Natl. Acad. Sci. 68:820–23 [Google Scholar]
  6. Easton E, Bishop D, Ford D. et al. 1993. Genetic linkage analysis in familial breast and ovarian cancer. Results from 214 families.. Am. J. Hum. Genet. 52:678–701 [Google Scholar]
  7. Rowell S, Newman B, Boyd J. et al. 1994. Inherited predisposition to breast and ovarian cancer.. Am. J. Hum. Genet. 55:861–65 [Google Scholar]
  8. Easton D, Ford D, Peto J. 1993. Inherited susceptibility to breast cancer.. Cancer Surv. 18:95–113 [Google Scholar]
  9. FitzGerald M, MacDonald D, Krainer M. et al. 1996. Germ-line BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer.. N. Engl. J. Med. 334:143–49 [Google Scholar]
  10. Langston A, Malone K, Thompson J. et al. 1996. BRCA1 mutations in a population-based sample of young women with breast cancer.. N. Engl. J. Med. 334:137–42 [Google Scholar]
  11. Struewing JP, Abeliovich D, Pertetz T. et al. The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals.. Nat. Genet. 11:198–200 [Google Scholar]
  12. Roa B, Boyd A, Volcik K. et al. 1996. Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2.. Nat. Genet. 14:185–87 [Google Scholar]
  13. Tonin P, Weber B, Offit K. et al. 1996. Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families.. Nat. Med. 2:1179–83 [Google Scholar]
  14. Struewing JP, Hartge P, Wacholder S. et al. 1997. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews.. N. Engl. J. Med. 336:1401–08 [Google Scholar]
  15. Krainer M, Silva-Arrieta S, Fitzgerald M. et al. 1997. Differential contributions of BRCA1 and BRCA2 to early-onset breast cancer.. N. Engl. J. Med. 336:1416–21 [Google Scholar]
  16. Wu L, Wang Z, Tsan J. et al. 1996. Identification of a RING protein that can interact in vivo with the BRCA1 gene product.. Nat. Genet. 14:430–40 [Google Scholar]
  17. Chapman M, Verma I. 1996. Transcriptional activation by BRCA1.. Nature 382:678–79 [Google Scholar]
  18. Monteiro A, August A, Hanafusa H. 1996. Evidence for a transcriptional activation function of BRCA1 C-terminal region.. Proc. Natl. Acad. Sci. 93:13595–99 [Google Scholar]
  19. Marquis S, Rajan J, Wynshaw-Boris A. et al. 1995. The developmental pattern of BRCA1 expression implies a role in differentiation of the breast and other tissues.. Nat. Genet. 11:17–28 [Google Scholar]
  20. Scully R, Ganesan S, Brown M. et al. 1996. Location of BRCA1 in human breast and ovarian cell lines.. Science 272:123–25 [Google Scholar]
  21. Scully R, Chen J, Plug A. et al. 1997. Association of BRCA1 with Rad51 in mitotic and meiotic cells.. Cell 88:265–75 [Google Scholar]
  22. Liu C, Flesken-Nitikin A, Li S. et al. 1996. Inactivation of the mouse BRCA1 gene leads to failure in the morphogenesis of the egg cylinder in early postimplantation development.. Genes Dev. 10:1835–43 [Google Scholar]
  23. Hakem R. et al. 1996. The tumor suppressor gene BRCA1 is required for embryonic cellular proliferation in the mouse.. Cell 85:1009–23 [Google Scholar]
  24. Wooster R, Bignell G, Lancaster J. et al. 1995. Identification of the breast cancer susceptibility gene BRCA2.. Nature 378:789–92 [Google Scholar]
  25. Tavtigian S, Simard J, Rommens J. et al. 1996. The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds.. Nat. Genet. 12:333–37 [Google Scholar]
  26. Oddoux C, Struewing J, Clayton C. et al. 1996. The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximnately 1%.. Nat. Genet. 14:188–90 [Google Scholar]
  27. Johannesdottir G, Gudmundsson J, Bergthorsson J. et al. 1996. High prevalence of the 999del5 mutation in Icelandic breast and ovarian cancer patients.. Cancer Res. 56:3663–65 [Google Scholar]
  28. Neuhausen S, Gilewski T, Norton L. et al. 1996. Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer.. Nat. Genet. 13:126–28 [Google Scholar]
  29. Couch F, Farid L, DeShano M. et al. 1996. BRCA2 germline mutations in male breast cancer cases and breast cancer families.. Nat. Genet. 13:123–26 [Google Scholar]
  30. Phelan C, Lancaster J, Tonin P. et al. 1996. Mutation analysis of the BRCA2 gene in 49 site-specific breast cancer families.. Nat. Genet. 13:120–22 [Google Scholar]
  31. Friedman L, Gayther S, Kurosaki T. et al. 1997. Mutation analysis of BRCA1 and BRCA2 in a male breast cancer population.. Am. J. Hum. Genet. 60:313–19 [Google Scholar]
  32. Teng D, Bogden R, MItchell J. et al. 1996. Low incidence of BRCA2 mutations in breast carcinoma and other cancers.. Nat. Genet. 13:241–44 [Google Scholar]
  33. Lancaster J, Wooster R, Mangion J. et al. 1996. BRCA2 mutations in primary breast and ovarian cancers.. Nat. Genet. 13:238–40 [Google Scholar]
  34. Rajan J, Wang M, Marquis S. et al. 1996. BRCA2 is coordinately regulated with BRCA1 during proliferation and differentiation in mammary epithelial cells.. Proc. Natl. Acad. Sci. 93:13078–83 [Google Scholar]
  35. Sharan S, Morimatsu M, Albrecht U. et al. 1997. Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking BRCA2.. Nature 386:804–10 [Google Scholar]
  36. Li F, Fraumeni J. 1969. Soft-tissue sarcomas, breast cancer, and other neoplasms: a familial syndrome?. Ann. Intern. Med. 71:747–52 [Google Scholar]
  37. Malkin D, Li F, Strong L. et al. 1990. Germline p53 mutations in a familial syndrome of breast cancer, sarcomas and other neoplasms.. Science 250:1233–38 [Google Scholar]
  38. Frebourg T, Barbier N, Yan Y. et al. 1995. Germline p53 mutations in 15 families with Li-Fraumeni syndrome.. Am. J. Hum. Genet. 56:608–15 [Google Scholar]
  39. Sidransky D, Tokino T, Helzlsouer K. et al. 1992. Inherited p53 gene mutations in breast cancer.. Cancer Res. 52:2984–86 [Google Scholar]
  40. Li J, Yen C, Liaw D. et al. 1997. PTEN, a putative tyrosine phophatase gene mutated in human brain, breast, and prostate cancer.. Science 275:1943–47 [Google Scholar]
  41. Steck P, Perhouse M, Jasser S. et al. 1997. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers.. Nat. Genet. 15:356–62 [Google Scholar]
  42. Liaw D, Marsh D, Li J. et al. 1997. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome.. Nat. Genet. 16:64–67 [Google Scholar]
  43. Lloyd K, Dennis M. 1963. Cowden's disease: a possible new symptom complex with multiple system involvement.. Ann. Intern. Med. 58:136–42 [Google Scholar]
  44. Starink TM, van der Veen J, Arwert F. et al. 1986. The Cowden syndrome: a clinical and genetic study in 21 patients.. Clin. Genet. 29:222–33 [Google Scholar]
  45. Swift M, Reitnauer P, Morrell D. et al. 1987. Breast and other cancers in families with ataxia-telangiectasia.. N. Engl. J. Med. 316:1289–94 [Google Scholar]
  46. Swift M, Morrell D, Massey R. et al. 1991. Incidence of cancer in 161 families affected by ataxia-telangiectasia.. N. Engl. J. Med. 325:1831–36 [Google Scholar]
  47. Athma P, Rappaport R, Swift M. 1996. Molecular genotyping shows that ataxia-telangiectasia heterozygotes are predisposed to breast cancer.. Cancer Genet. Cytogenet. 92:130–34 [Google Scholar]
  48. FitzGerald MG, Bean JM, Hegde SR. et al. 1997. Heterozygous ATM mutations do not contribute to early onset of breast cancer.. Nat. Genet 15:307–10 [Google Scholar]
  49. Krontiris T, Devlin B, Karp D. et al. 1993. An association between the risk of cancer and mutations in the HRAS1 minisatellite locus.. N. Engl. J. Med. 329:517–23 [Google Scholar]
  50. Phelan C, Rebbeck T, Weber B. et al. 1996. Ovarian cancer risk in BRCA1 carriers is modified by the HRAS1 variable number of tandem repeat (VNTR) locus.. Nat. Genet. 12:309–11 [Google Scholar]
  51. Schrag D, Kuntz KM, Garber JE, Weeks JC. 1997. Decision analysis-effects of prophylactic mastectomy and oophorectomy on life expectancy among women with BRCA1 or BRCA2 mutations.. N. Engl. J. Med. 336:1465–71 [Google Scholar]
  52. Piver M, Jishi M, Tsukada Y. et al. 1993. Primary peritoneal carcinoma after prophylactic oophorectomy in women with a family history of ovarian cancer.. Cancer 71:2751–55 [Google Scholar]
  53. Collins FS. 1996. BRCA1–lots of mutations, lots of dilemmas.. N. Engl. J. Med. 334:186–88 [Google Scholar]
  54. Ishioka C, Suzuki T, Fitzgerald M. et al. 1997. Detection of heterozygous truncating mutations in the BRCA1 and APC genes by using a rapid screening assay in yeast.. Proc. Natl. Acad. Sci. 94:2449–53 [Google Scholar]
/content/journals/10.1146/annurev.med.49.1.425
Loading
Hereditary Breast Cancer
Annual Review of Medicine 49, 425 (1998); https://doi.org/10.1146/annurev.med.49.1.425
/content/journals/10.1146/annurev.med.49.1.425
/content/journals/10.1146/annurev.med.49.1.425
Loading

Data & Media loading...

  • Article Type: Review Article

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error